{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:34:15Z","timestamp":1758630855941},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1007\/bf01703232","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:14:12Z","timestamp":1118538852000},"page":"175-180","source":"Crossref","is-referenced-by-count":14,"title":["Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment"],"prefix":"10.1007","volume":"66","author":[{"given":"Y.","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01703232_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.2830350103","volume":"35","author":"I Aoki","year":"1990","unstructured":"Aoki I, Higashi K, Homori M, Chikazawa H, Ishikura K (1990) Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Epo) in vitro in aplastic anemia and myelodysplastic syndromes. Am J Hematol 35: 6\u201312","journal-title":"Am J Hematol"},{"key":"BF01703232_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189\u2013199","journal-title":"Br J Haematol"},{"key":"BF01703232_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0609.1990.tb00343.x","volume":"44","author":"DT Bowen","year":"1990","unstructured":"Bowen DT, Jacobs A, Cotes MP, Lewis TC (1990) Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Eur J Haematol 44: 30\u201332","journal-title":"Eur J Haematol"},{"key":"BF01703232_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2141.1991.tb08594.x","volume":"77","author":"DT Bowen","year":"1991","unstructured":"Bowen DT, Culligan D, Jacobs A (1991) The treatment of anemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br J Haematol 77: 419\u2013423","journal-title":"Br J Haematol"},{"key":"BF01703232_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM198203183061105","volume":"306","author":"B Camitta","year":"1982","unstructured":"Camitta B, Storb R, Thomas D (1982) Aplastic anemia, pathogenesis, diagnosis, treatment and prognosis. N Engl J Med 306: 645\u2013652","journal-title":"N Engl J Med"},{"key":"BF01703232_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V79.1.29.29","volume":"79","author":"M Cazzola","year":"1992","unstructured":"Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E (1992) Subcutaneous erythropoietin for treatment of refractory anemia in haematologic disorder. Results of a phase-I\/II clinical trial. Blood 79: 29\u201337","journal-title":"Blood"},{"key":"BF01703232_CR7","first-page":"429","volume":"109","author":"AJ Erslev","year":"1987","unstructured":"Erslev AJ, Wilson J, Caro J (1987) Erythropoietin titers in anemic, nonuremic subjects. J Lab Clin Med 109: 429\u2013433","journal-title":"J Lab Clin Med"},{"key":"BF01703232_CR8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","volume":"321","author":"JW Esbach","year":"1982","unstructured":"Esbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW (1982) Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321: 158\u2013163","journal-title":"N Engl J Med"},{"key":"BF01703232_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0609.1991.tb01860.x","volume":"47","author":"E Hellstrom","year":"1991","unstructured":"Hellstrom E, Birgegard G, Lockner D, Helmers C, Ost A, Wide L (1991) Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol 47: 355\u2013360","journal-title":"Eur J Haematol"},{"key":"BF01703232_CR10","first-page":"657","volume":"17","author":"K Hirashima","year":"1989","unstructured":"Hirashima K, Bessho M, Susaki K, Miyazawa K, Nagashima M (1989) Improvement of anemia by intravenous injections of recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Exp Hematol 17: 657","journal-title":"Exp Hematol"},{"key":"BF01703232_CR11","first-page":"288","volume":"9","author":"D Hoelzer","year":"1990","unstructured":"Hoelzer D, Ganser A, Seipelt G, Ottmann O, Hoffken K, Boogaerts M, Verhoef G, Lutz D, Krieger O, de Witte T, Diehl L, Lathan B, Ferrant A, Martiat P, Klausmann M, Gandhi D, Frisch J, Schulz G (1990) Hematopoietic growth factors (HGF) in the treatment of patients with myelodysplastic syndromes. Proc ASCO 9: 288 (abstr 1117)","journal-title":"Proc ASCO"},{"key":"BF01703232_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.1989.tb00215.x","volume":"73","author":"A Jacobs","year":"1989","unstructured":"Jacobs A, Janowska-Wieczonek A, Caro J, Bowen DT, Lewis T (1989) Circulating erythropoietin in patients with myelodysplastic syndromes. Br J Haematol 73: 36\u201339","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"BF01703232_CR13","first-page":"170 a","volume":"76","author":"H Kamp van","year":"1990","unstructured":"Kamp H van, Prinsze-Postema TC, Kluin PLM, den Ottolander GJ, Willemze R, Fibbe WE (1990) Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. Blood 76: [Suppl 1] 170 a (abstr 671)","journal-title":"Blood"},{"key":"BF01703232_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0009-8981(89)90040-5","volume":"185","author":"K Matsubara","year":"1989","unstructured":"Matsubara K, Yoshimura T, Kamachi S, Fukushima M, Hino M, Mori M (1989) Radioimmunoassay for erythropoietin using anti-recombinant erythropoietin antibody with high affinity. Clin Chim Acta 185: 177\u2013184","journal-title":"Clin Chim Acta"},{"key":"BF01703232_CR15","first-page":"771","volume":"4","author":"S Merchav","year":"1980","unstructured":"Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Seigalla P, Wieczorek L (1980) In vitro studies of epo-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia 4: 771\u2013774","journal-title":"Leukemia"},{"key":"BF01703232_CR16","first-page":"432","volume":"5","author":"HC Schouten","year":"1991","unstructured":"Schouten HC, Vellenga E, van Rhenen DJ, de Wolf JJM, Coppens PNJ, Blijham GH (1991) Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 5: 432\u2013436","journal-title":"Leukemia"},{"key":"BF01703232_CR17","first-page":"204","volume":"9","author":"MW Schuster","year":"1990","unstructured":"Schuster MW, Allen SL, Lichtman SM, Schulman P, De Marco LC, Budman DR, Muusa WT (1990) The use of erythropoietin in the treatment of myelodysplastic syndrome and myelofibrosis. Proc ASCO 9: 204 (abstr 789)","journal-title":"Proc ASCO"},{"key":"BF01703232_CR18","first-page":"1204","volume":"18","author":"C Stebler","year":"1990","unstructured":"Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen K, Speck B (1990) High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria. A pilot study. Exp Hematol 18: 1204\u20131208","journal-title":"Exp Hematol"},{"key":"BF01703232_CR19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","volume":"78","author":"RS Stein","year":"1991","unstructured":"Stein RS, Abels RI, Krantz SB (1991) Pharmacologic dose of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 78: 1658\u20131663","journal-title":"Blood"},{"key":"BF01703232_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/stem.5530050304","volume":"5","author":"A Urabe","year":"1987","unstructured":"Urabe A, Saito T, Fukamachi H, Kubota M, Takaku F (1987) Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. Int J Cell Cloning 5: 202\u2013208","journal-title":"Int J Cell Cloning"},{"key":"BF01703232_CR21","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V75.8.1749.1749","volume":"75","author":"S Vadhan-Raj","year":"1990","unstructured":"Vadhan-Raj S, Hittelman W, Lepe-Zwinge J, Gutterman JU, Broxmeyer HE (1990) Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes. Blood 75: 1749\u20131750","journal-title":"Blood"},{"key":"BF01703232_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01811466","volume":"64","author":"GEG Verhoef","year":"1992","unstructured":"Verhoef GEG, Zachee P, Ferrant A, Demvynck H, Selleslage D, Deckers F, Boogaerts MA (1992) Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment. Ann Hematol 64: 16\u201321","journal-title":"Ann Hematol"},{"key":"BF01703232_CR23","unstructured":"Yoshida Y, Stephenson J, Mufti GJ (1993) Myelodysplastic syndromes from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasias. Int J Hematol (in press)"},{"key":"BF01703232_CR24","first-page":"1092","volume":"51","author":"Y Yoshida","year":"1988","unstructured":"Yoshida Y, Ohmori S, Tohyama K, Uchino H, Sawanishi K, Itoh M, Sohma T, Kuze H (1988) Erythropoietic changes in chronic hemodialysis patients undergoing human erythropoietin therapy. Acta Haematol Jpn 51: 1092\u20131096","journal-title":"Acta Haematol Jpn"},{"key":"BF01703232_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.2830110110","volume":"11","author":"CG Zalouris","year":"1981","unstructured":"Zalouris CG, Hoffman BJ, Kourides IA (1981) Serum concentrations of erythropoietin measured by radioimmunoassay in hematologic disorders and chronic renal failure. Am J Hematol 11: 85\u201392","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703232\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:16:20Z","timestamp":1586279780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["BF01703232"],"URL":"https:\/\/doi.org\/10.1007\/bf01703232","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}